concept

CYTOKINE

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CYTOKINE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1569Connections

9Hypotheses

0Analyses

50Outgoing

50Incoming

5Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	CYTOKINE
Key Genes/Proteins	ABL1, AMYLOID, amyotrophic lateral sclerosis, ANXIETY
Related Diseases	aging, Alzheimer'S Disease

Pathway Diagram

graph TD
    CYTOKINE["CYTOKINE"]
    CYTOKINE ---|"co-discussed"| MITOCHONDRIA["MITOCHONDRIA"]
    CYTOKINE ---|"co-discussed"| TDP_43["TDP-43"]
    CYTOKINE ---|"co-discussed"| ER_STRESS["ER STRESS"]
    CYTOKINE ---|"co-discussed"| IL6["IL6"]
    CYTOKINE ---|"co-discussed"| OCLN["OCLN"]
    CYTOKINE ---|"co-discussed"| MICROGLIA["MICROGLIA"]
    ALS["ALS"] ---|"co-discussed"| CYTOKINE
    CLDN5["CLDN5"] ---|"co-discussed"| CYTOKINE
    AUTOPHAGY["AUTOPHAGY"] ---|"co-discussed"| CYTOKINE
    COMPLEMENT["COMPLEMENT"] ---|"co-discussed"| CYTOKINE
    APOPTOSIS["APOPTOSIS"] ---|"co-discussed"| CYTOKINE
    AKT["AKT"] ---|"co-discussed"| CYTOKINE

Outgoing (439)

Target	Relation	Type	Str
Depression	associated_with	disease	0.60
Aging	therapeutic_target	disease	0.60
Stroke	activates	disease	0.60
Parkinson	activates	disease	0.60
Aging	inhibits	disease	0.60
Cancer	activates	disease	0.60
Leukemia	activates	disease	0.60
Neurodegeneration	biomarker_for	disease	0.60
Neuroinflammation	biomarker_for	disease	0.60
Diabetes	activates	disease	0.60
Fibrosis	activates	disease	0.60
Addiction	inhibits	disease	0.60
Glioblastoma	inhibits	disease	0.60
Obesity	activates	disease	0.60
Frontotemporal Dementia	therapeutic_target	disease	0.60
Dementia	therapeutic_target	disease	0.60
Stroke	regulates	disease	0.60
Neuropathy	causes	disease	0.60
Neurodegeneration	therapeutic_target	disease	0.60
Autism	expressed_in	disease	0.60
Amyotrophic Lateral Sclerosis	therapeutic_target	disease	0.60
Dementia	expressed_in	disease	0.60
Glioblastoma	activates	disease	0.60
Ischemia	associated_with	disease	0.60
Aging	causes	disease	0.60
Chronic Pain	regulates	disease	0.60
Ferroptosis	activates	disease	0.60
Parkinson	regulates	disease	0.60
Alzheimer	expressed_in	disease	0.60
Encephalitis	associated_with	disease	0.60
Parkinson	expressed_in	disease	0.60
Autism	contributes_to	disease	0.60
Dementia	causes	disease	0.60
Neurodegeneration	protects_against	disease	0.60
Als	causes	disease	0.60
Traumatic Brain Injury	inhibits	disease	0.60
Neuroinflammation	inhibits	disease	0.60
Traumatic Brain Injury	activates	disease	0.60
Amyotrophic Lateral Sclerosis	activates	disease	0.60
Obesity	regulates	disease	0.60
Necroptosis	activates	disease	0.60
Neurodegeneration	inhibits	disease	0.60
Multiple Sclerosis	inhibits	disease	0.60
Pyroptosis	expressed_in	disease	0.60
Aging	associated_with	disease	0.60
Cancer	associated_with	disease	0.60
Ferroptosis	associated_with	disease	0.60
Senescence	associated_with	disease	0.60
Atherosclerosis	activates	disease	0.60
Leukemia	inhibits	disease	0.60

Incoming (1130)

Source	Relation	Type	Str
JUN	associated_with	gene	0.60
RIPK3	activates	gene	0.60
CD4	inhibits	gene	0.60
IL1B	associated_with	gene	0.60
EXERCISE	inhibits	gene	0.60
XIAP	activates	gene	0.60
PARKINSON	activates	gene	0.60
CD8	inhibits	gene	0.60
TLR4	activates	gene	0.60
MMP9	associated_with	gene	0.60
TAU	causes	gene	0.60
PHAGOCYTOSIS	inhibits	gene	0.60
NOD2	activates	gene	0.60
MAPK	activates	gene	0.60
GPR37	associated_with	gene	0.60
GPR37	activates	gene	0.60
FUS	therapeutic_target	gene	0.60
SOD1	therapeutic_target	gene	0.60
PD-1	inhibits	gene	0.60
STAT1	activates	gene	0.60
ANXIETY	associated_with	gene	0.60
IL-17	activates	gene	0.60
NGF	activates	gene	0.60
DEMENTIA	causes	gene	0.60
MAPK	contributes_to	gene	0.60
AMYLOID	activates	gene	0.60
ALS	activates	gene	0.60
RIPK1	activates	gene	0.60
RIPK2	activates	gene	0.60
NF-KB	activates	gene	0.60
ALOX15	associated_with	gene	0.60
BANG	activates	gene	0.60
PHAGOCYTOSIS	activates	gene	0.60
STROKE	activates	gene	0.60
C9ORF72	therapeutic_target	gene	0.60
DEMENTIA	therapeutic_target	gene	0.60
ALS	therapeutic_target	gene	0.60
TARDBP	therapeutic_target	gene	0.60
RNA	inhibits	gene	0.60
PRDM1	inhibits	gene	0.60
TREM2	activates	gene	0.60
ALZHEIMER	activates	gene	0.60
STAT3	activates	gene	0.60
EGFR	activates	gene	0.60
PYROPTOSIS	activates	gene	0.60
CXCL1	associated_with	gene	0.60
CXCL8	associated_with	gene	0.60
TLR2	associated_with	gene	0.60
P38	contributes_to	gene	0.60
PRKN	activates	gene	0.60

Targeting Hypotheses (9)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Astrocyte-Microglia Communication Rebalancing via Cytokine M	0.655	neurodegeneration	Which cell types show the most significa
Mitochondrial-Cytokine Axis Modulation	0.532	neurodegeneration	Gene expression changes in aging mouse b
Closed-loop neuromodulation-inspired cytokine axis suppressi	0.530	cell-biology	-
Temporal Cytokine Receptor Modulation	0.455	chronobiology	Can circadian interventions reverse micr
Compensatory Cytokine Network Activation	0.455	clinical-neurology	Why do systemic anti-inflammatory drugs

Microglial State-Dependent Cytokine Function	0.455	clinical-neurology	Why do systemic anti-inflammatory drugs
CNS-Peripheral Cytokine Compartmentalization	0.455	clinical-neurology	Why do systemic anti-inflammatory drugs
STAT3 Epigenetic Priming as Mechanism of Peripheral Cytokine	0.347	immunomics	Systemic immune profiling in neurodegene
Temporal Cytokine Window Therapeutic Intervention	0.000	-	Blood-brain barrier tight junction disru

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (5)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Model	Status	Est. Cost
LPS-induced mouse model of depression with synaptic loss analysis	validation	depression	0.900	LPS-treated mice	proposed	N/A
Network pharmacology analysis of QTJD active compounds and pathways	exploratory	Mycoplasma pneumoniae pneumoni	0.900	computational network analysis	proposed	N/A
Bidirectional Mendelian randomization analysis of C1Q and ischemic str	exploratory	Ischemic stroke, Atheroscleros	0.900	Human genetic association data	proposed	N/A
Bidirectional Mendelian randomization analysis of C1Q and ischemic str	exploratory	Ischemic stroke (large artery	0.900	human genetic data	proposed	N/A
C1q neutralizing antibody intervention in depression model	validation	depression	0.850	LPS-treated mice with C1q anti	proposed	N/A

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning CYTOKINE in their description or question text

Microglial State-Dependent Cytokine Function

Score: 0.455 · clinical-neurology · 2026-04-27

TNF-α and IL-6 serve protective functions in homeostatic microglia but become pathogenic in disease-associated microglia

CNS-Peripheral Cytokine Compartmentalization

Score: 0.455 · clinical-neurology · 2026-04-27

The blood-brain barrier creates distinct cytokine microenvironments where peripheral TNF-α/IL-6 inhibition fails to reac

STAT3 Epigenetic Priming as Mechanism of Peripheral Cytokine Memory

Score: 0.347 · immunomics · 2026-04-25

STAT3 Epigenetic Priming as Mechanism of Peripheral Cytokine Memory

Temporal Cytokine Window Therapeutic Intervention

Score: 0.000 · unknown disease · 2026-04-28

Sequential IL-1β receptor antagonist treatment followed by Wnt pathway activation targeting the 6-24 hour post-injury wi